Serum activated leukocyte cell adhesion molecule and intercellular adhesion molecule-1 in patients with gastric cancer: Can they be used as biomarkers?

Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
Kayhan ErturkBurak Sakar

Abstract

Cellular adhesion molecules might be used as markers in diagnosis and prognosis in some types of malignant tumors. The purpose of this study was to determine the clinical significance of the serum levels of activated leukocyte cell adhesion molecule-1 (ALCAM) and intercellular adhesion molecule-1 (ICAM-1) in gastric cancer (GC) patients. Fifty-eight GC patients and 20 age- and sex-matched healthy controls were enrolled into this study. Pretreatment serum markers were determined by the solid-phase sandwich enzyme-linked immunosorbent assay (ELISA). The median age at diagnosis was 59.5 years (range 32-82 years). Tumor localizations of the majority of the patients were antrum (n=42, 72.4%) and tumor histopathologies of the majority of the patients were diffuse (n=43, 74.1%). The majority of the patients had stage IV disease (n=41, 70.7%). Thirty six (62.1%) patients had lymph node involvement. The median follow-up time was 66 months (range 1-97.2 months). At the end of the observation period, 26 patients (44.8%) were dead. The median survival for all patients was 21.4±5 months (%95 CI, 11.5-31.3). The 1-year survival rates were 66.2%. The baseline serum ALCAM levels of the patients were significantly higher than those of the contr...Continue Reading

References

Oct 1, 1993·Immunology Today·A J Gearing, W Newman
Jan 1, 1996·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·A van de Stolpe, P T van der Saag
Apr 21, 1998·Surgery Today·T KitagawaK Iriyama
Jun 26, 1998·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P Sánchez-RoviraE Aranda
Nov 27, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·D AlexiouC Tsigris
Jul 13, 2002·International Journal of Cancer. Journal International Du Cancer·Yukinobu MaruoKunzo Orita
Oct 29, 2004·Journal of Clinical Pathology·W WeichertG Kristiansen
Jan 18, 2006·Digestive Diseases and Sciences·Masakazu YashiroKosei Hirakawa
Feb 18, 2006·Journal of Clinical Pathology·M BurkhardtG Kristiansen
Oct 24, 2007·Clinical & Experimental Metastasis·Olivier De WeverMarc Bracke
Jan 4, 2008·Molecular Cancer Research : MCR·Ombretta RossoMarina Fabbi
Feb 19, 2008·Translational Research : the Journal of Laboratory and Clinical Medicine·Solomon F Ofori-Acquah, Judy A King
Oct 30, 2008·Analytical and Bioanalytical Chemistry·Jon LaddShaoyi Jiang
Mar 27, 2009·International Journal of Cancer. Journal International Du Cancer·Vathany KulasingamEleftherios P Diamandis
May 13, 2010·Journal of Surgical Oncology·Xin HongJörg Kleeff
Oct 5, 2010·Journal of Surgical Oncology·Sumiya IshigamiShoji Natsugoe
Aug 23, 2011·International Journal of Cancer. Journal International Du Cancer·Michael TachezyMaximilian Bockhorn
Jun 30, 2012·PloS One·Michael TachezyMaximilian Bockhorn
Nov 22, 2012·International Journal of Cancer. Journal International Du Cancer·Grazia CarbottiMarina Fabbi
Jan 16, 2013·Proteomics·Seham ChakerPaul G Walfish

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.